Medtronic ICD COBALT XT implants may deliver reduced or no therapy
Medtronic's ICD COBALT XT HF QUAD implantable defibrillators may deliver reduced or no energy output during high voltage therapy. The FDA has classified this as a Class I recall.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which establishes a minimum severity of 4 per the rubric. Although the hazard is described as a 'rare potential' and no illnesses have been reported, FDA Class I classification indicates a reasonable probability of serious harm. The inability to deliver electrical therapy from an implanted defibrillator poses direct risk to patient safety.
Plain-English summary
Medtronic Inc. is recalling ICD COBALT XT HF QUAD OUS implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), devices used to deliver electrical therapy for dangerous heart rhythms. The recall affects 9 units manufactured with a specific feedthrough component.
There is a rare potential for these devices to deliver reduced or no energy output during high voltage therapy (typically 0–12 joules). This malfunction could prevent the device from properly terminating dangerous arrhythmias when therapy is needed.
Affected devices were distributed nationwide and worldwide. Patients with the following serial numbers may have devices at risk: RTC614024S, RTC617998S, RTC614026S, RTC617999S, RTC618002S, RTC618007S, RTC621332S, RTC614023S, and RTC611661S. The FDA has classified this as a Class I recall.
Patients should contact their healthcare provider or Medtronic immediately to determine if their device is affected and discuss next steps.
The recalled product
- Product
- ICD COBALT XT HF QUAD OUS, Model Number DTPA2QQG; Implantable Cardioverter Defibrillators
- Affected units
- 9
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- GTIN 00763000501020
- Lot Serial Numbers: RTC614024S
- RTC617998S
- RTC614026S
- RTC617999S
- RTC618002S
- RTC618007S
- RTC621332S
- RTC614023S
- RTC611661S
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 120 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 120 products in this recall →Related recalls
Same manufacturer · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
See all →- CriticalMedtronic CRT-D Defibrillators: Rare Energy Output Failure Risk During Therapy
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillators Recalled for Reduced Therapy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators at Risk of Reduced Energy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillator may lose energy output during therapy
FDA (Devices) · 2023-06-28
Same hazard · device malfunction
See all →- HighPhilips Incisive CT Recalled for Potential Failure to Trigger Clinical Scan
FDA (Devices) · 2026-09-02
- HighBoston Scientific Recalls Suture Cinch Endoscopic Tissue Approximation Devices
FDA (Devices) · 2026-08-26
- HighBD Needle Kit for Powered Driver Recall Due to Removal Difficulty
FDA (Devices) · 2026-08-26
- SevereStryker AHTO Tube Set Packaging Recalled for Handpiece Leaking
FDA (Devices) · 2026-08-12
- SevereGEM Premier 5000 PAK Lysing Solution Concentration Recall
FDA (Devices) · 2026-08-12